The final results of the Phase I prime-boost AIDS (Acquired Immune Deficiency Syndrome) vaccine trial started in February 2009 and conducted at the two sites — Tuberculosis Research Centre (TRC), Chennai, and the National AIDS Research Institute (NARI), Pune — has shown that the vaccines are safe and their ability to elicit immune response are modest.
Links:
[1] http://admin.indiaenvironmentportal.org.in/node/336647
[2] http://admin.indiaenvironmentportal.org.in/category/author/r-prasad
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/hindu-new-delhi
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/aids
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vaccination
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/new-york
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/immunisation
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/pune-d
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/national-tuberculosis-institute
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health